RA PHARMACEUTICALS INC's ticker is RARX and the CUSIP is 74933V108. A total of 121 filers reported holding RA PHARMACEUTICALS INC in Q3 2019. The put-call ratio across all filers is 1.29 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $17,572,000 | -21.3% | 743,000 | 0.0% | 0.58% | -14.4% |
| Q2 2019 | $22,342,000 | +177.1% | 743,000 | +106.4% | 0.68% | +145.1% |
| Q1 2019 | $8,062,000 | +14.2% | 359,900 | -7.2% | 0.28% | -11.5% |
| Q4 2018 | $7,062,000 | +0.6% | 388,000 | 0.0% | 0.31% | +21.3% |
| Q3 2018 | $7,019,000 | +81.8% | 388,000 | 0.0% | 0.26% | +61.2% |
| Q2 2018 | $3,861,000 | +87.4% | 388,000 | 0.0% | 0.16% | +66.7% |
| Q1 2018 | $2,060,000 | +41.1% | 388,000 | +288.0% | 0.10% | +15.7% |
| Q3 2017 | $1,460,000 | -22.1% | 100,000 | 0.0% | 0.08% | -29.1% |
| Q2 2017 | $1,874,000 | – | 100,000 | – | 0.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NEA Management Company, LLC | 6,138,797 | $145,183,000 | 12.02% |
| VHCP Management III, LLC | 670,350 | $15,854,000 | 9.79% |
| RA Capital Management | 4,858,260 | $114,898,000 | 6.85% |
| VHCP Management II, LLC | 677,164 | $16,015,000 | 6.10% |
| EMORY UNIVERSITY | 59,690 | $1,412,000 | 2.78% |
| SECTORAL ASSET MANAGEMENT INC | 451,247 | $10,672,000 | 1.84% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,728,019 | $40,868,000 | 1.67% |
| Opaleye Management Inc. | 141,800 | $3,354,000 | 1.21% |
| ACUTA CAPITAL PARTNERS, LLC | 55,000 | $1,301,000 | 0.94% |
| EAM Global Investors LLC | 69,035 | $1,633,000 | 0.80% |